ArticleThe Journal of infectious diseases2021
Rubella Eradication: Not Yet Accomplished, but Entirely Feasible.
Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.
- Rubella antibody levels in the healthy Chinese population: a meta-analysis.Frontiers in immunology · 2024Pooled it
- How to Prevent Rubella Epidemics and Congenital Rubella Syndrome: Lessons From 42 Years of Longitudinal Epidemiology in Osaka Prefecture, Japan (1982-2023).The Journal of infectious diseases · 2025Article
- Optimal control prevents itself from eradicating stochastic disease epidemics.PLoS computational biology · 2025Article
- Rubella epidemiology in Lesotho after vaccine introduction: a five-year review, 2018-2022.BMC public health · 2024Article
- Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics.Vaccines · 2024Review
- Rubella virus chronic inflammatory disease and other unusual viral phenotypes in inborn errors of immunity.Immunological reviews · 2024Review
- Rubella virus-associated uveitis at a tertiary care hospital in Germany between 2013 and 2019.BMC ophthalmology · 2023Article
- Do adolescents need a rubella vaccination campaign? Rubella serosurvey among healthy children in Hangzhou, China.Human vaccines & immunotherapeutics · 2023Article
- Rubella virus tropism and single-cell responses in human primary tissue and microglia-containing organoids.eLife · 2023Article
- Seroprevalence of rubella virus infection among antenatal care clients of Halaba Town public health facilities, southern Ethiopia.Scientific reports · 2023Article
- Rubella Virus Infections: A Bibliometric Analysis of the Scientific Literature from 2000 to 2021.Healthcare (Basel, Switzerland) · 2022Article
- Review
- Epidemiological characteristic of rubella by age group during 12 years after the national introduction of rubella vaccine in Hangzhou, China.Human vaccines & immunotherapeutics · 2022Article
- Investing in global measles and rubella elimination is needed to avert deaths and advance health equity.The Lancet. Global health · 2022Article
- Rubella Virus-Associated Granulomas in Immunocompetent Adults-Possible Implications.JAMA dermatology · 2022Article
- Importation and circulation of rubella virus lineages 1E-L2 and 2B-L2c between 2018 and 2021 in China: Virus evolution and spatial-temporal transmission characteristics.Virus evolution · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rubella virus is the most teratogenic virus known to science and is capable of causing large epidemics. The RA 27/3 rubella vaccine, usually combined with measles vaccine, has eliminated rubella and congenital rubella syndrome from much of the world, notably from the Western Hemisphere. Except in immunosuppressed individuals, it is remarkably safe. Together with rubella vaccine strains used in China and Japan, eradication of the rubella virus is possible, indeed more feasible than eradication of measles or mumps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.